Picture of SNDL logo

SNDL — SNDL News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapValue Trap

Sndl Inc Reports Results For The Quarter Ended In September 30: Earnings Summary

* SNDL Inc  SNDL.OQ  reported a quarterly adjusted loss of 7
cents​​ per share for the quarter ended September 30.  The lone
analyst forecast for the quarter was for a loss of 5 cents per
share. 
    * Revenue was $236.89 million​; analysts expected $232.40
million. 
    * SNDL Inc's reported EPS for the quarter was a loss of 7
cents​.
    * SNDL Inc shares had risen by 4.9% this quarter and
gained 31.7%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for SNDL Inc is 3.50 
This summary was machine generated from LSEG data November 6 at
04:59 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.05          -0.07          Missed

Recent news on SNDL

See all news